Stage-specific role for Shh in dopaminergic differentiation of human embryonic stem cells induced by stromal cells

Stem Cells and Development

Volumn 19, Issue 1, 2010, Pages 71-82

  Swistowska, Anna Maria ^a   Da Cruz, Alexandre Bettencourt ^a   Han, Yi ^a   Swistowski, Andrzej ^a   Liu, Ying ^b   Shin, Soojung ^b   Zhan, Ming ^c   Rao, Mahendra S ^a,b   Zeng, Xianmin ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b INVITROGEN CORPORATION   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROTEIN; SHH PROTEIN; SOMATOMEDIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL STRAIN; CELL STRAIN PA6; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CLEAVAGE STAGE, OVUM; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DOPAMINE; EMBRYONIC INDUCTION; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; HEDGEHOG PROTEINS; HUMANS; MICE; NEUROGENESIS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STROMAL CELLS;

PRIMATES;

EID: 75749103824     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0107     Document Type: Article

References (53)

1. Perlow MJ, WJ Freed, BJ Hoffer, A Seiger, L Olson and RJ Wyatt. (1979). Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643-647.
2. Bjorklund A, SB Dunnett, U Stenevi, ME Lewis and SD Iversen. (1980). Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res 199:307-333.
3. Freed WJ, MJ Perlow, F Karoum, A Seiger, L Olson, BJ Hoffer and RJ Wyatt. (1980). Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann Neurol 8:510-519.
4. Studer L, V Tabar and RD McKay. (1998). Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1:290-295.
5. Bjorklund LM, R Sanchez-Pernaute, S Chung, T Andersson, IY Chen, KS McNaught, AL Brownell, BG Jenkins, C Wahlestedt, KS Kim and O Isacson. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99:2344-2349.
6. Kim JH, JM Auerbach, JA Rodriguez-Gomez, I Velasco, D Gavin, N Lumelsky, SH Lee, J Nguyen, R Sanchez-Pernaute, K Bankiewicz and R McKay. (2002). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56.
7. Freed CR, RE Breeze, NL Rosenberg, SA Schneck, TH Wells, JN Barrett, ST Grafton, SC Huang, D Eidelberg and DA Rottenberg. (1990). Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch Neurol 47:505-512. (Pubitemid 20155837)
8. Freed CR, RE Breeze, NL Rosenberg, SA Schneck, E Kriek, JX Qi, T Lone, YB Zhang, JA Snyder, TH Wells, LO Rami, L Thompson, JC Mazziotta, SC Huang, ST Grafton, D Brooks, G Sawle, G Schroter and AA Ansari. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555.
9. Lindvall O, G Sawle, H Widner, JC Rothwell, A Bjorklund, D Brooks, P Brundin, R Frackowiak, CD Marsden, P Odin and S Rehncrona. (1994). Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35:172-180.
10. Kordower JH, TB Freeman, BJ Snow, FJ Vingerhoets, EJ Mufson, PR Sanberg, RA Hauser, DA Smith, GM Nauert, DP Perl and CW Olanow. (1995). Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124.
11. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
12. Amit M, MK Carpenter, MS Inokuma, CP Chiu, CP Harris, MA Waknitz, J Itskovitz-Eldor and JA Thomson. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227:271-278.
13. Cowan CA, I Klimanskaya, J McMahon, J Atienza, J Witmyer, JP Zucker, S Wang, CC Morton, AP McMahon, D Powers and DA Melton. (2004). Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353-1356.
14. Iacovitti L, AE Donaldson, CE Marshall, S Suon and M Yang. (2007). A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo. Brain Res 1127(1):19-25.
15. Park S, KS Lee, YJ Lee, HA Shin, HY Cho, KC Wang, YS Kim, HT Lee, KS Chung, EY Kim and J Lim. (2004). Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci Lett 359:99-103.
16. Perrier AL, V Tabar, T Barberi, ME Rubio, J Bruses, N Topf, NL Harrison and L Studer. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 101:12543-12548.
17. Buytaert-Hoefen KA, E Alvarez and CR Freed. (2004). Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 22:669-674.
18. Zeng X, J Cai, J Chen, Y Luo, ZB You, E Fotter, Y Wang, B Harvey, T Miura, C Backman, GJ Chen, MS Rao and WJ Freed. (2004). Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22:925-940. (Pubitemid 39507080)
19. Schulz TC, SA Noggle, GM Palmarini, DA Weiler, IG Lyons, KA Pensa, AC Meedeniya, BP Davidson, NA Lambert and BG Condie. (2004). Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22:1218-1238.
20. Yan Y, D Yang, ED Zarnowska, Z Du, B Werbel, C Valliere, RA Pearce, JA Thomson and SC Zhang. (2005). Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23:781-790.
21. Martinat C, JJ Bacci, T Leete, J Kim, WB Vanti, AH Newman, JH Cha, U Gether, H Wang and A Abeliovich. (2006). Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA 103:2874-2879.
22. Ueno M, M Matsumura, K Watanabe, T Nakamura, F Osakada, M Takahashi, H Kawasaki, S Kinoshita and Y Sasai. (2006). Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix. Proc Natl Acad Sci USA 103:9554-9559.
23. Roy NS, C Cleren, SK Singh, L Yang, MF Beal and SA Goldman. (2006). Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12(11):1259-1268.
24. Park CH, YK Minn, JY Lee, DH Choi, MY Chang, JW Shim, JY Ko, HC Koh, MJ Kang, JS Kang, DJ Rhie, YS Lee, H Son, SY Moon, KS Kim and SH Lee. (2005). In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 92(5):1265-1276.
25. Kawasaki H, K Mizuseki, S Nishikawa, S Kaneko, Y Kuwana, S Nakanishi, SI Nishikawa and Y Sasai. (2000). Induction of midbrain dopaminergic neurons from ES cells by stromal cellderived inducing activity. Neuron 28:31-40.
26. Hayashi H, A Morizane, M Koyanagi, Y Ono, Y Sasai, N Hashimoto and J Takahashi. (2008). Meningeal cells induce dopaminergic neurons from embryonic stem cells. Eur J Neurosci 27:261-268.
27. Sonntag KC, J Pruszak, T Yoshizaki, J van Arensbergen, R Sanchez-Pernaute and O Isacson. (2007). Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 25:411-418.
28. Schwartz CM, CE Spivak, SC Baker, TK McDaniel, JF Loring, C Nguyen, FJ Chrest, R Wersto, E Arenas, X Zeng, WJ Freed and MS Rao. (2005). NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev 14:517-534.
29. Vazin T, J Chen, CT Lee, R Amable and WJ Freed. (2008). Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells. Stem Cells 26:1517-1525.
30. Brimble SN, X Zeng, DA Weiler, Y Luo, Y Liu, IG Lyons, WJ Freed, AJ Robins, MS Rao and TC Schulz. (2004). Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13:585-597.
31. Shin S, M Mitalipova, S Noggle, D Tibbitts, A Venable, R Rao and SL Stice. (2006). Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 24:125-138.
32. Zeng X, J Chen, JF Sanchez, M Coggiano, O Dillon-Carter, J Petersen and WJ Freed. (2003). Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells 21:647-653
33. Bolstad BM, RA Irizarry, M Astrand and TP Speed. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
34. Shin S, Y Sun, Y Liu, H Khaner, S Svant, J Cai, QX Xu, BP Davidson, SL Stice, AK Smith, SA Goldman, BE Reubinoff, M Zhan, MS Rao and JD Chesnut. (2007). Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue. Stem Cells 25:1298-1306.
35. Roussa E, O Oehlke, B Rahhal, S Heermann, S Heidrich, M Wiehle and K Krieglstein. (2008). Transforming growth factor beta cooperates with persephin for dopaminergic phenotype induction. Stem Cells 26:1683-1694.
36. Castelo-Branco G, J Wagner, FJ Rodriguez, J Kele, K Sousa, N Rawal, HA Pasolli, E Fuchs, J Kitajewski and E Arenas. (2003). Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci USA 100:12747-12752.
37. Vernay B, M Koch, F Vaccarino, J Briscoe, A Simeone, R Kageyama and SL Ang. (2005). Otx2 regulates subtype specification and neurogenesis in the midbrain. J Neurosci 25:4856-4867.
38. Chen JK, J Taipale, MK Cooper and PA Beachy. (2002). Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 16:2743-2748.
39. Andersson E, U Tryggvason, Q Deng, S Friling, Z Alekseenko, B Robert, T Perlmann and J Ericson. (2006). Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124:393-405.
40. Dahlstrand J, M Lardelli and U Lendahl. (1995). Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Brain Res Dev Brain Res 84:109-129.
41. Pevny LH, S Sockanathan, M Placzek and R Lovell-Badge. (1998). A role for SOX1 in neural determination. Development 125:1967-1978.
42. Simeone A. (2005). Genetic control of dopaminergic neuron differentiation. Trends Neurosci 28:62-65; discussion 65-66.
43. Alberi L, P Sgado and HH Simon. (2004). Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131:3229-3236.
44. Smidt MP, CH Asbreuk, JJ Cox, H Chen, RL Johnson and JP Burbach. (2000). A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci 3:337-341.
45. Zetterstrom RH, L Solomin, L Jansson, BJ Hoffer, L Olson and T Perlmann. (1997). Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248-250.
46. Nunes I, LT Tovmasian, RM Silva, RE Burke and SP Goff. (2003). Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci USA 100:4245-4250.
47. Hynes M and A Rosenthal. (1999). Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr Opin Neurobiol 9:26-36.
48. Hynes M, K Poulsen, M Tessier-Lavigne and A Rosenthal. (1995). Control of neuronal diversity by the floor plate: contact-mediated induction of midbrain dopaminergic neurons. Cell 80:95-101.
49. Lee SH, N Lumelsky, L Studer, JM Auerbach and RD McKay. (2000). Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18:675-679.
50. Kim HJ, M Sugimori, M Nakafuku and CN Svendsen. (2006). Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Exp Neurol 203:394-405.
51. Chung S, BS Shin, M Hwang, T Lardaro, UJ Kang, O Isacson and KS Kim. (2006). Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells 24:1583-1593.
52. Cai C, J Thorne and L Grabel. (2008). Hedgehog serves as a mitogen and survival factor during embryonic stem cell neurogenesis. Stem Cells 26:1097-1108.
53. Cai J, A Donaldson, M Yang, MS German, G Enikolopov and L Iacovitti. (2009). The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model. Stem Cells 27220-27229